Johnson & Johnson Reports Q4 and Full-Year 2023 Results : vi

2023 Fourth-Quarter reported sales growth of 7.3% to $21.4 Billion with operational growth of 7.2%* and adjusted operational growth of 5.7%*. Operational growth excluding COVID-19 Vaccine of...

Related Keywords

China , Japan , Johnson Medtech , Joaquin Duato , Ashley Mcevoy , Biosense Webster , Johnson Medtech Acquires Laminar Inc , Exchange Commission , Development Expense , European Medicines Agency , European Medicines Agency Seeking Approval Of Lazertinib , Research Development Expense , Consumer Health Company , Abiomed , Interventional Solutions , Johnson , Drug Administration Grants Full Approval , Company Consumer Health , Chief Executive , Innovative Medicine , General Surgery , New Announcements , Current Reports , Quarterly Reports , Annual Reports , Investor Relations , News Releases , Treat Locally , Metastatic Bladder Cancer , Select Genetic , Webster Announces Regulatory Approval , Field Ablation , Submits Marketing Authorisation Application , European Medicines Agency Seeking Approval , First Line Treatment , Mutated Non Small Cell Lung Cancer , New Drug Application , Plus Lazertinib , Therapy Designation , High Risk Non Muscle Invasive Bladder Cancer , Submits Application , Adult Patients , Prior Therapy , Bronchoscopy Receives Regulatory License , Patient Reported Outcomes , Adults Living With Active Psoriatic Arthritis , Data Establish Proof , Adults Living , Severe Rheumatoid Arthritis , Combination Study , Data Demonstrate Very High Power , Short Duration Ablations Improved Quality , Reduced Healthcare Utilization , Ulcerative Colitis Show , Overall Clinical Response Rate , Early Symptom Improvement , Define New Standards , Solid Tumor Cancers , Transformative Data Planned , Sealing Patch , Clinically Proven , Stop Disruptive Bleeding , Acquire Ambrx , Johnson Announces Key Drivers , Long Term Competitive Growth , Enterprise Business Review , Johnson Names Eugene , Chief Executive Officer , Advocate Health , Johnson Medtech Acquires Laminar , Johnson Medtech Provides Details , General Surgery Robot , Johnson Announces Departure , Tim Schmid Named Executive Vice President , Worldwide Chairman , Shares Outstanding , Euro Average Rate , Average Shares Outstanding , Investors Concerning Forward Looking Statements , Private Securities Litigation Reform Act , Consumer Health , New Consumer Health Company , Annual Report , Note Regarding Forward Looking , Consolidated Statement , Millions Except Per Share Figures , Discontinued Operations , Continuing Operations , Millions Except Per Share Data , Asset Amortization , Net Earnings , Medical Device Regulation , European Medical Devices Directive , Sales Reconciliation , Income Before Tax , Segment From Continuing , Reported Research , Markets ,